Skip to content
GullySales
GullySales
Tell us what you need

Pharmaceutical manufacturers · Lead generation

Bring in franchise partners and distributors who hold a licence and can sell.

Lead generation for a pharmaceutical manufacturer means attracting PCD partners, stockists, institutional buyers and contract clients who fit what your plant supplies, not everyone who asks for a price list. GullySales works on the search pages, screening questions and enquiry routing that put those buyers in front of your team.

Tell us what you needor call +91 80958 58589

Scope, fee, reporting and term are agreed in writing after we have read your brief and spoken to you.

Pharmaceutical staff inspect sealed medicine packs in a cleanroom

What lead generation means

Lead generation is the combined work of every channel that brings in a new enquiry, whether from search, adverts, referrals or a stall at an exhibition. GullySales runs these channels together and reports the number of enquiries each one produced, not the activity behind it.

Also for pharmaceutical manufacturers

Sales and marketing for pharmaceutical manufacturers, the overview.

Last updated 18 Oct 2026.

For pharmaceutical manufacturers

Where it usually goes wrong, and what we would do.

  • “A price-list request is not a partner enquiry”

    Someone who types a franchise search and asks for the rate list may be a chemist, a student or a competitor checking prices. The enquiry that matters comes from a person with a drug licence, a territory and a stockist network, and the first form should ask for exactly those facts.

  • “Each territory is a separate pool of buyers”

    A district already held by an active partner is closed, while the next one may be open. Leads that arrive without a territory attached waste calls, because your team learns only on the phone that the area has been given away.

  • “Institutional buyers search differently”

    A hospital purchase officer or tender cell looks for vendor registration details, certificates and a named contact, not a franchise offer. Treating that person as one more PCD lead sends a pitch they have no use for.

  • “Contract manufacturing enquiries arrive with a brief”

    A brand owner looking for a third-party plant asks about dosage forms, licences held and minimum batch sizes. That enquiry deserves a technical reply from someone who knows the plant, not a generic callback.

What we do

What we deliver for pharmaceutical manufacturers.

The work available for this need. We agree the deliverables and responsibilities for your engagement in writing.

  1. Partner screening form

    Questions on drug licence, territory, existing stockist network and products currently handled, with a score of your own choosing.

    Result: Your team sees at a glance which enquiries are worth a call.

  2. Territory-aware enquiry pages

    Franchise pages by state or district that say which territories are open, so the enquirer names an area first.

    Result: Each enquiry arrives with a territory to check against your partner list.

  3. Separate routes for each buyer

    Distinct enquiry paths for PCD partners, distributors, institutional buyers and contract clients, each reaching the person who handles it.

    Result: No hospital buyer gets a franchise call and no franchise seeker lands on the tender desk.

  4. Search and outreach aimed at your ranges

    Search ads and outreach lists built around the therapy areas and territories where you want partners, with wording checked by your regulatory head.

    Result: Spend can be traced to the territory and range it was meant for.

  5. Enquiry source log

    A record of where each enquiry came from and what became of it.

    Result: You can see which sources produced partners who reordered and which produced only rate requests.

How the result is measured

  • Enquiries generated
  • Cost per enquiry
  • Enquiries by source

Recorded as a baseline before work starts, so every later report has an honest comparison.

Read the full demand and lead generation page

What to capture or send

The first form decides whether the enquiry is a partner or a price hunter.

Each field below filters for a buyer who can hold a licence and sell, and gives your team something to say on the first call.

Drug licence status
Whether the enquirer already holds a wholesale or retail licence. It separates a ready PCD partner from someone who still has to apply.
Territory asked for
The district or state the enquirer wants, checked against partners you have already appointed there before anyone replies.
Current stockist network
A line on the chemists and doctors the enquirer already supplies. It shows whether they can sell your range or only hold the agency.
Ranges of interest
The dosage forms or therapy areas asked about, so the reply carries the right list and not the whole catalogue.
Buyer type
Franchise partner, stockist, hospital purchase officer or contract client. Each gets a different reply and a different owner on your team.
Source of the enquiry
Search, directory, exhibition or referral, recorded at entry so you can see which route brings partners who place a first order.

Who it is for

This is written for these pharmaceutical manufacturers.

  • Tablet and capsule formulation companies
  • Injectable and infusion manufacturers
  • Syrup, suspension and oral liquid plants
  • Ointment, cream and topical manufacturers
  • Ophthalmic and ENT drop makers
  • Ayurvedic and herbal formulation companies
  • Nutraceutical and food supplement manufacturers
  • Veterinary medicine manufacturers

Not for

It is not the right fit if.

  • Your plant cannot supply a new territory yet, so more partner enquiries would only produce promises you cannot keep.
  • No senior person is free to call the strongest enquiries, and a good partner lead left waiting goes to another company.

Before you decide

Agree the work. Know how to judge it.

Lead generation for pharmaceutical manufacturers: use these checks to prepare, choose the scope, and review what changes.

Bring the right evidence

Define the organisations or buyers you can serve and the reasons they would consider a conversation. Bring examples of accepted and rejected prospects so the selection rule is visible.

Make the scope clear

Agree the research sources, contact approach, qualification rules, and handover. Clarify which meetings count as accepted and what happens to replies that are not ready to buy.

Check the work in use

Review why a prospect was selected and what was learned from the response. Count held, relevant conversations separately from contacts found, messages sent, or meetings booked.

Know when to change course

If the same objection appears repeatedly, adjust the offer or buyer group before increasing outreach. Respect a request to stop contact and keep the exclusion in the record.

These are discussion points, not a fixed package. GullySales confirms the deliverables, responsibilities, fee, and term in writing after reading your brief and speaking with you.

How it works

How the lead generation work runs

The work itself, in order. How an engagement starts, from your brief to a written scope, is set out on our method page.

  1. 1

    Requirements and capacity decision

    Send the requirements brief, then discuss your offer and available sales capacity with us. You receive the scope, fee, and term in writing before committing to the work.

  2. 2

    Source review and baseline approval

    We review available enquiry records and channel dashboards. You confirm the starting figures for enquiries by source, reply time, conversion, and cost per order, including gaps in the records.

  3. 3

    Offer and capture approval

    Your sales lead approves the audience and the questions needed before a call. Page copy and contact-use wording go through your internal review before publication.

  4. 4

    Test enquiry and sales handoff

    We test the agreed routes from submission to the shared record and first reply. The person responsible for sales checks that the record contains enough information to act.

  5. 5

    Launch and source decisions

    Traffic starts on the approved channels. We compare enquiry quality with the baseline and use your sales outcomes to decide which sources need changes or less spend.

Where this fits

Three pieces of sales work, in this order.

This work sits inside sales process design, at stage 1, prospecting and lead generation. The audit comes before it, and sales management keeps it running.

  1. Step 1

    Sales audit

    Find where deals are being lost and what to fix first.

    Start here if you cannot say where orders are lost.

  2. Step 2 · you are here

    Sales process design

    One written way to sell, from first enquiry to repeat order.

    Start here if every salesperson sells differently.

  3. Step 3

    Sales management

    A target, a review routine and someone who owns the number.

    Start here if the team has targets and no routine.

Tell us what you need Your brief is read before we call. Scope, fee and term in writing.

FAQ

Questions owners ask before they call.

Not here? More answers, or ask on WhatsApp.

Tell us what you need
How do we stop collecting price-list seekers?
Ask for the drug licence, the territory and the current stockist network on the first form, and state plainly what the franchise requires. Those without answers drop out, and the ones who answer arrive with the facts your team needs.
Should the owner call every enquiry?
The owner's time belongs to the strongest enquiries. Score each one on the screening answers, give the strong ones to a senior caller and send the rest a written reply with the range and terms.
Can we advertise our formulations to the public?
Rules on promoting medicines differ by product type, by profession and by state, so check the wording with your own regulatory head or adviser before anything goes live. Partner-facing pages stay on company and range information.
What if a partner asks for a territory already given to someone else?
Say so plainly and offer a neighbouring territory or a place on the waiting list. Telling the truth early protects the existing partner, and an enquirer who hears it from you is more likely to return when a territory opens.
How long is the contract?
The term is agreed in writing after we have spoken, along with the fee and the reporting. It is never a default twelve months, and renewal is decided on the numbers against the baseline recorded at the start.
How soon will we see results?
It depends on the trade, the channel and what is already in place. After we have read your brief and spoken to you, we say what we would expect to move first and how it will be measured against the baseline. Nothing here is guaranteed.
Who will actually do the work?
The person you speak to before anything starts. We work from one office in Nagarbhavi, Bengaluru, with no account managers in between.
What do you need from us?
Your brief, and a conversation. After that, access to whatever this work touches, such as your website, your accounts or your enquiry record, and time with the people who handle your enquiries.

More for pharmaceutical manufacturers

Related work to consider.

Closest to this: leads and follow-up

Also for pharmaceutical manufacturers

Or start from the overview: sales and marketing for pharmaceutical manufacturers.

Your next practical step

Tell us what you are trying to grow, and we will read it before we call.

Eight short steps, mostly taps. Skip anything you would rather answer on the call.

Tell us what you need